This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Famotidine in Schizophrenia
Clinical trial

Famotidine in Schizophrenia

Read time: 1 mins
Last updated:23rd Aug 2013
Objective of the trial is to study if famotidine add-on treatment is more effective than placebo add-on in reducing symptoms of schizophrenia among patients receiving insufficient response to ongoing antipsychotic treatment.
Category Value
Study start date 2013-08-23

View full details